Improving the lives of people with Down syndrome through advanced biomedical research
We use state-of-the-art, transformational research platforms to decipher the unique biology and disease spectrum caused by trisomy of chromosome 21.
Our ultimate goal is to enable precision medicine approaches to improve health outcomes in Down syndrome, including the development of new diagnostic and therapeutic tools.
Crnic Institute scientists publish metabolomics study revealing kynurenine pathway activation in trisomy 21
Dr. Potter is featured on the CU Anschutz 360 podcast for a candid discussion about the state of Alzheimer’s research
Our annual Down Syndrome Research Symposium is on September 25th at the Anschutz Campus
Sie Center clinicians evaluate the association of dysphagia with age and other respiratory comorbidities
We are the largest geographical cluster of Down syndrome researchers in the world
Comprised of over 50 Principal Investigators and countless more contributing scientists from across the University of Colorado campuses, our researchers bring expertise from a variety of fields.
Together, we are working to decipher the complex mechanisms and multi-faceted health impacts of trisomy 21.
